reason report
price chang estim chang analysi
reiter rate increas former
price target per share compani fiscal
oper result reflect number move piec clearli
invest year remain pois realiz durabl high-
mid-single-digit organ revenu growth realiz oper
leverag accordingli share like open mix
base modest miss remain continu
see opportun acceler organ revenu growth myday
capac increas misight rolled-out ecp increasingli
fit astigmat patient toric new fertil contract commenc
addit csi gross oper margin stand
improv rel fiscal level dtc spend normal
manufactur varianc absorb result modest earn
leverag signific increas
increas price increas former
price target per share revis price
target assum non-gaap earn multipl versu
former price target assum price-to-earnings
chang estim increas former
revenu estim million million former
non-gaap ep estim per share per share
likewis increas former million revenu
per share non-gaap earn estim million
per share respect ep estim revis
summar tabl left
valuat summari share current trade
revenu adjust ebitda
peer trade like multipl respect
cooper compani inc headquart
pleasanton california global medic product
compani serv specialti healthcar market
two busi unit coopervis
develop market broad rang contact
lens coopersurg csi develop
manufactur market medic devic
diagnost product surgic instrument
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
guidanc updat reiter revenu guidanc rang million
million pre-cal consensu million csi revenu rang million million pre-cal
consensu million result compani continu forecast total revenu rang
million million pre-cal consensu million furthermor compani increas non-gaap
earn guidanc prior rang per share revis rang per share
per share pre-cal consensu per share updat forecast effect tax rate compar
prior guidanc lastli compani continu expect million incur
million capit expenditur
coronaviru updat manufactur packag oper china countri
account total revenu compani anticip million neg headwind fy revenu
consist million advers impact primarili due loss specialti len sale via hospit china
million advers impact csi chines fertil busi howev compani maintain revenu
guidanc due improv myday manufactur capac new contract fertil busi addit
expect global oper return normal may furthermor note compani anticip
portion lost sale come back throughout year importantli guidanc reflect
assumpt lost sale regain
misight control launch materi potenti oper period misight gener revenu
million year-over-year slightli ahead compani intern expect addit
compani end februari children wear misight lens end fiscal
oper period furthermor children misight lens addit doctor
contract compani first round misight educ certif top univers importantli
compani continu forecast misight revenu million million million
recal conserv estim domest opportun myopic control rang million
million introduc contact len wear initi vision correct modal averag wearer life may doubl
impli increment annual retail len sale per wearer million myopia control
addit estim annual wearer drop-out rate could reduc end reduct yield
estim million annual len sale assum daili sihi asp
balanc sheet review fiscal oper period gener million oper cash flow
incur million capit expenditur yield free cash flow million result compani
exit fiscal oper period million cash cash equival debt million
net debt posit million net debt per share
consolid gaap statement incom
million except per share data
fiscal period
fiscal period
fiscal period
good sold cog
 amort intang
compani file stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
